Goldman Z, Ebstein R P, Lerer B, Zohar J, Hermoni M, Belmaker R H
Neuropsychobiology. 1981;7(6):281-4. doi: 10.1159/000117861.
Haloperidol levels were measured by radioreceptor assay in 12 schizophrenic patients during gradual dosage reduction (at 10-day) intervals) from 60 to 0 mg/day. Serum levels were highly correlated with the oral dose in each patient, but poorly correlated across patients. Clinical deterioration appeared only 10-20 days after total cessation of the oral drug, and so it was not possible to determine an optimal blood level for chronic maintenance. Below oral dosage of 10 mg/day of haloperidol many patients' blood levels are undetectable by the radioreceptor method.
通过放射受体分析法对12例精神分裂症患者在逐渐减量(每隔10天)过程中,从每日60毫克减至0毫克时的氟哌啶醇水平进行了测定。每位患者的血清水平与口服剂量高度相关,但不同患者之间的相关性较差。临床恶化仅在口服药物完全停用后10 - 20天才出现,因此无法确定慢性维持治疗的最佳血药浓度。当氟哌啶醇口服剂量低于每日10毫克时,许多患者的血药浓度通过放射受体法无法检测到。